Dr. Ansell on Combining CAR T-cell Therapy and Immunotherapy in Lymphomas – OncLive
|
Dr. Ansell on Combining CAR T-cell Therapy and Immunotherapy in Lymphomas
OncLive Stephen M. Ansell, MD, PhD, chair of the Lymphoma Group at Mayo Clinic, discusses the possibility of blending immunotherapy agents with chimeric antigen receptor (CAR) T-cell therapy across lymphoma populations. A therapeutic approach like this is … |
